Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients ; volume:24 ; number:1 ; day:25 ; month:10 ; year:2024 ; pages:1-8 ; date:12.2024
BMC health services research ; 24, Heft 1 (25.10.2024), 1-8, 12.2024
- Urheber
-
Yorio, Jeffrey Thomas
Asnis-Alibozek, Aviva G.
Kasturi, Vijay
Hutson, Thomas E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-024-11587-8
- URN
-
urn:nbn:de:101:1-2501152103319.818603171748
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yorio, Jeffrey Thomas
- Asnis-Alibozek, Aviva G.
- Kasturi, Vijay
- Hutson, Thomas E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram
TKi | TKi
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
TKi
TKI
TKi
TKI
"TKi"
TKI
TKi
TKi
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram
TKi | TKi
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
TKi
TKI
TKi
TKI
"TKi"
TKI
TKi
TKi
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram
TKi | TKi
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
TKi
TKI
TKi
TKI
"TKi"
TKI
TKi